ArticleScientific reports2023

Exploring preferences and decision-making about long-acting injectable HIV pre-exposure prophylaxis (PrEP) among young sexual minority men 17-24 years old.

Steven A John et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.